Filing Details

Accession Number:
0000921895-20-002115
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-06 16:23:47
Reporting Period:
2020-08-05
Accepted Time:
2020-08-06 16:23:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
727510 Enzon Pharmaceuticals Inc. ENZN Biological Products, (No Disgnostic Substances) (2836) 222372868
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1265094 Jonathan Couchman 600 Fifth Avenue
2Nd Floor
New York NY 10020
No No Yes No
1413616 Cooper Michael Pearce 193 Audubon Trail
Cashiers NC 28717
No No No Yes
1459450 Myrexis, Inc. 600 Fifth Avenue
2Nd Floor
New York NY 10020
No No Yes No
1571659 Xstelos Corp. 1105 North Market Street
Suite 1300
Wilmington DE 19801
No No Yes No
1586910 Harper Asset Management Llc 2248 Mariner Dr.
Longmont CO 80503
No No No Yes
1700373 James Brian Harper 2248 Mariner Dr.
Longmont CO 80503
No No No Yes
1737322 Fund Family Couchman 600 Fifth Avenue
2Nd Floor
New York NY 10020
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.01 Par Value Acquisiton 2020-08-05 506,292 $0.20 2,100,524 No 4 P Indirect By Xstelos Corp.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Xstelos Corp.
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.01 Par Value 4,717,666 Indirect By Jonathan Couchman
Common Stock, $0.01 Par Value 400,000 Indirect By Couchman Family Fund
Common Stock, $0.01 Par Value 633,264 Indirect By Myrexis, Inc.
Common Stock, $0.01 Par Value 1,667,294 Indirect By Harper Asset Management LLC
Common Stock, $0.01 Par Value 0 Indirect By Michael Pearce
Footnotes
  1. This Form 4 is filed jointly by Jonathan Couchman ("Mr. Couchman"), Couchman Family Fund (the "Foundation"), Xstelos Corp. ("Xstelos") and Myrexis, Inc. ("Myrexis"), Brian Harper, Harper Asset Management, LLC ("HAM"), and Michael Pearce, (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons expressly disclaims beneficial ownership of the Shares reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such Shares for purposes of Section 16 or for any other purpose.
  2. Represents shares owned directly by Mr. Couchman. As the sole trustee of the Foundation, Mr. Couchman may be deemed to beneficially own the Shares owned by the Foundation. As the Chief Executive Officer of Xstelos, Mr. Couchman may be deemed to beneficially own the shares of Common Stock owned by Xstelos. As the Chief Executive Officer of Myrexis, Mr. Couchman may be deemed to beneficially own Shares of Common Stock owned by Myrexis.
  3. Represents Shares owned directly by the Foundation. Mr. Couchman is the sole trustee of the Foundation. By virtue of this relationship, Mr. Couchman may be deemed to beneficially own the Shares owned directly by the Foundation, however he has no pecuniary interest in such Shares.
  4. Represents Shares owned directly by Xstelos. Mr. Couchman is the controlling shareholder and Chief Executive Officer of Xstelos. By virtue of these relationships, Mr. Couchman may be deemed to beneficially own the Shares owned directly by Xstelos. Mr. Couchman expressly disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein.
  5. Represents Shares owned directly by Myrexis. Mr. Couchman is Chief Executive Officer of Myrexis. By virtue of this relationship, Mr. Couchman may be deemed to beneficially own the Shares owned directly by Myrexis. Mr. Couchman expressly disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein.
  6. Represents shares owned directly by HAM. Mr. Harper is the President of HAM. By virtue of this relationship, Mr. Harper may be deemed to beneficially own the Shares owned directly by HAM. Mr. Harper expressly disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein.
  7. Represents shares owned directly by Michael Pearce. Mr. Pearce expressly disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein.